These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 12735230)
1. Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemia. Inazu A; Mabuchi H Curr Opin Investig Drugs; 2003 Mar; 4(3):291-7. PubMed ID: 12735230 [TBL] [Abstract][Full Text] [Related]
2. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease. Barter PJ; Kastelein JJ J Am Coll Cardiol; 2006 Feb; 47(3):492-9. PubMed ID: 16458126 [TBL] [Abstract][Full Text] [Related]
3. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Okamoto H; Yonemori F; Wakitani K; Minowa T; Maeda K; Shinkai H Nature; 2000 Jul; 406(6792):203-7. PubMed ID: 10910363 [TBL] [Abstract][Full Text] [Related]
4. Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians. Forrester JS; Makkar R; Shah PK Circulation; 2005 Apr; 111(14):1847-54. PubMed ID: 15824213 [TBL] [Abstract][Full Text] [Related]
5. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796 [TBL] [Abstract][Full Text] [Related]
6. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis. Klerkx AH; El Harchaoui K; van der Steeg WA; Boekholdt SM; Stroes ES; Kastelein JJ; Kuivenhoven JA Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):706-15. PubMed ID: 16439711 [TBL] [Abstract][Full Text] [Related]
7. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. Kuivenhoven JA; Jukema JW; Zwinderman AH; de Knijff P; McPherson R; Bruschke AV; Lie KI; Kastelein JJ N Engl J Med; 1998 Jan; 338(2):86-93. PubMed ID: 9420339 [TBL] [Abstract][Full Text] [Related]
8. Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits. Kee P; Caiazza D; Rye KA; Barrett PH; Morehouse LA; Barter PJ Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):884-90. PubMed ID: 16373610 [TBL] [Abstract][Full Text] [Related]
9. Raising high-density lipoprotein with cholesteryl ester transfer protein inhibitors. Clark RW Curr Opin Pharmacol; 2006 Apr; 6(2):162-8. PubMed ID: 16487747 [TBL] [Abstract][Full Text] [Related]
10. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus. de Vries R; Borggreve SE; Dullaart RP Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331 [TBL] [Abstract][Full Text] [Related]
11. Study on cholesteryl ester transfer activity in coronary heart disease. Fujinuma Y; Tanaka A; Maezawa H Bull Tokyo Med Dent Univ; 1991 Sep; 38(3):27-33. PubMed ID: 1934199 [TBL] [Abstract][Full Text] [Related]
12. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. Schaefer EJ; Asztalos BF Am J Cardiol; 2007 Dec; 100(11 A):n25-31. PubMed ID: 18047849 [TBL] [Abstract][Full Text] [Related]
13. Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: relationship to abnormalities in high-density lipoprotein. Hiraoka H; Yamashita S; Matsuzawa Y; Kubo M; Nozaki S; Sakai N; Hirano K; Kawata S; Tarui S Hepatology; 1993 Jul; 18(1):103-10. PubMed ID: 8325601 [TBL] [Abstract][Full Text] [Related]
14. Refocusing on use of cholesteryl ester transfer protein inhibitors. Kastelein JJ Am J Cardiol; 2007 Dec; 100(11 A):n47-52. PubMed ID: 18047853 [TBL] [Abstract][Full Text] [Related]
15. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine. Carrilho AJ; Medina WL; Nakandakare ER; Quintão EC Clin Pharmacol Ther; 1997 Jul; 62(1):82-8. PubMed ID: 9246022 [TBL] [Abstract][Full Text] [Related]
16. Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver. Gauthier A; Lau P; Zha X; Milne R; McPherson R Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2177-84. PubMed ID: 16123327 [TBL] [Abstract][Full Text] [Related]
17. [Cholesterol ester transfer protein. A major player in cholesterol metabolism]. Hansen PR Ugeskr Laeger; 1999 Sep; 161(38):5295-8. PubMed ID: 10536513 [TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients. Kimura H; Miyazaki R; Suzuki S; Gejyo F; Yoshida H Am J Kidney Dis; 2001 Jul; 38(1):70-6. PubMed ID: 11431184 [TBL] [Abstract][Full Text] [Related]
19. CETP inhibition in cardiovascular risk management: a critical appraisal. Dullaart RP; Dallinga-Thie GM; Wolffenbuttel BH; van Tol A Eur J Clin Invest; 2007 Feb; 37(2):90-8. PubMed ID: 17217373 [TBL] [Abstract][Full Text] [Related]
20. Lipoprotein profile and cholesteryl ester transfer protein in neonates. Kaser S; Ebenbichler CF; Wolf HJ; Sandhofer A; Stanzl U; Ritsch A; Patsch JR Metabolism; 2001 Jun; 50(6):723-8. PubMed ID: 11398152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]